Our latest publication, Clinical and Cognitive Improvement Following Full-Spectrum, High-Cannabidiol Treatment for Anxiety: Open-Label Data from a Two-Stage, Phase 2 Clinical Trial, was featured in an article by Sarah Sinclair of Cannabis Health News.
The article summarizes findings from the open-label clinical trial, including reduced anxiety and improvements in mood, sleep and quality of life. Read it here.